BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7184669)

  • 1. Salivary phenytoin concentrations in geriatric patients.
    Umstead GS; McKernan TM
    Clin Pharm; 1982; 1(1):54-8. PubMed ID: 7184669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monitoring therapy by analysis of the drug concentration of saliva].
    Bartels H; Günther E; Wallis S
    Monatsschr Kinderheilkd; 1983 Jan; 131(1):13-6. PubMed ID: 6835213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary free concentrations of anti-epileptic drugs: an evaluation in a routine clinical setting.
    al Za'abi M; Deleu D; Batchelor C
    Acta Neurol Belg; 2003 Mar; 103(1):19-23. PubMed ID: 12704979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring phenytoin in salivary and plasma ultrafiltrates of pediatric patients.
    Bachmann K; Forney RB; Voeller K
    Ther Drug Monit; 1983; 5(3):325-9. PubMed ID: 6636260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of phenobarbitone and phenytoin therapy in small children by salivary samples.
    Mucklow JC; Bacon CJ; Hierons AM; Webb JK; Rawlins MD
    Ther Drug Monit; 1981; 3(3):275-7. PubMed ID: 7324092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of toxic anticonvulsant drug concentrations in mentally retarded persons with epilepsy.
    Aman MG; Paxton JW; Field CJ; Foote SE
    Am J Ment Defic; 1986 May; 90(6):643-50. PubMed ID: 3717220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ineffectiveness of folic acid supplementation against phenytoin-induced decrease in salivary immunoglobulin A concentration of epileptic patients.
    Zare M; Ghazvini MR; Yazdi HR; Nezhad VS; Chitsaz A
    Eur Neurol; 2008; 59(6):299-301. PubMed ID: 18408370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of total, free, and salivary phenytoin concentrations in geriatric patients.
    Umstead GS; Morales M; McKercher PL
    Clin Pharm; 1986 Jan; 5(1):59-62. PubMed ID: 3948486
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenytoin blood concentrations in hospitalized geriatric patients: oral versus nasogastric feeding tube administration.
    Lubart E; Berkovitch M; Leibovitz A; Orly D; Segal R
    Ther Drug Monit; 2010 Apr; 32(2):185-8. PubMed ID: 20216111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenytoin therapy and immune response to influenza vaccine.
    Levine M; Beattie BL; McLean DM; Corman D
    Clin Pharm; 1985; 4(2):191-4. PubMed ID: 3987219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data.
    Battino D; Croci D; Mamoli D; Messina S; Perucca E
    Epilepsy Res; 2004; 59(2-3):155-65. PubMed ID: 15246117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary phenytoin radioimmunoassay. A simple method of the assessment of non-protein bound drug concentrations.
    Paxton JW; Rowell F; Ratcliffe JG; Lambie DG; Nanda R; Melville ID; Johnson RH
    Eur J Clin Pharmacol; 1977; 11(1):71-4. PubMed ID: 832662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary phenytoin concentrations in epilepsy and in chronic renal failure.
    Reynolds F; Ziroyanis PN; Jones NF; Smith SE
    Lancet; 1976 Aug; 2(7982):384-6. PubMed ID: 73850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation.
    Chambers MS; Tomsett KL; Artopoulou II; Garden AS; El-Naggar AK; Martin JW; Keene HJ
    J Prosthet Dent; 2008 Aug; 100(2):142-6. PubMed ID: 18672129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of drug monitoring with saliva--the influence of phenytoin upon the salivary inorganic constituents].
    Watanabe S; Igarashi S; Ichida T
    Rinsho Byori; 1986 Mar; 34(3):254-61. PubMed ID: 3712786
    [No Abstract]   [Full Text] [Related]  

  • 16. Dehydroepiandrosterone sulfate in saliva.
    Lagrelius A; Fridström M; Möllerström G; Carlström K
    Acta Obstet Gynecol Scand; 1988; 67(4):359-61. PubMed ID: 2972163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary levels of IL-1beta, IL-6, IL-8, and TNF-alpha in patients with burning mouth syndrome.
    Suh KI; Kim YK; Kho HS
    Arch Oral Biol; 2009 Sep; 54(9):797-802. PubMed ID: 19555923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Confirmation of a workable relationship between saliva and plasma phenytoin concentrations in man as measured by radioimmunoassay].
    Alric R; Blayac JP; Negre C; Baldy-Moulinier M; Passouant P
    Therapie; 1978; 33(3):333-9. PubMed ID: 684685
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison between blood serum and salivary cortisol concentrations in horses using an adrenocorticotropic hormone challenge.
    Peeters M; Sulon J; Beckers JF; Ledoux D; Vandenheede M
    Equine Vet J; 2011 Jul; 43(4):487-93. PubMed ID: 21496072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of three methods for predicting concentrations of free phenytoin.
    Beck DE; Farringer JA; Ravis WR; Robinson CA
    Clin Pharm; 1987 Nov; 6(11):888-94. PubMed ID: 3677566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.